ABVC BioPharma Signs Agreement To License Certain Of Its Healthcare-Related 'Know-How' To Senior Paradise; Co. To Receive License Fees Of $3M And Royalties Of 2% On Future Revenues
Portfolio Pulse from Benzinga Newsdesk
ABVC BioPharma has entered into a licensing agreement with Senior Paradise, granting them access to specific healthcare-related 'know-how'. In return, ABVC will receive an upfront license fee of $3M and future royalties of 2% on revenues generated from this knowledge.
February 15, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ABVC BioPharma's licensing deal with Senior Paradise includes a $3M upfront fee and 2% royalties on future revenues, indicating a new revenue stream.
The agreement provides ABVC BioPharma with an immediate cash infusion of $3M, which is positive for its short-term financial health. The 2% royalties on future revenues also suggest a potential for ongoing income, depending on the success of the licensed 'know-how'. This deal could be seen positively by investors as it opens up a new revenue stream and demonstrates the value of ABVC's intellectual property.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100